Here's a recap of the most exciting parts of Investor Day today 1. Management are very confident they will achieve 10,000 transplants. That's the publicly stated goal but they have sites FAR larger than that. 2. Currently, we're only utilizing less than 20% of lungs, less than 30% of hearts, and ~60% livers. This means the vast majority of the donor pool is completely untapped. 3. There's a lot of $TransMedics Group, Inc.(TMDX)$ competitors out there that are not solving the issue of ischemia. Ischemic damage is the damage that occurs when there's no blood supply to an organ. The longer this happens for, the increased chance of morbidity. There's no competitor out there that has a product that is able to eliminate ischemic damage AND bring the org